✦ LIBER ✦

Renal Impairment Does Not Affect the Glycemic Efficacy or Safety of Liraglutide Treatment in Patients with Type 2 Diabetes

✍ Scribed by Gough, Stephen; Feldt-Rasmussen, Bo; Davidson, Jaime; Govindaraju, Vasanthi; Donsmark, Morten; Scott, David

Book ID: 123450897
Publisher: Canadian Diabetes Association
Year: 2012
Tongue: English
Weight: 131 KB
Volume: 36
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2012.07.326

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

One-year safety, tolerability and effica

One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment

✍ W. Kothny; Q. Shao; P.-H. Groop; V. Lukashevich 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

Efficacy and Safety of Liraglutide vs. P

Efficacy and Safety of Liraglutide vs. Placebo as Add-On to Existing Diabetes Medication in Subjects with Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL)

✍ Ngo, Phuong; Davies, Melanie; Atkin, Stephen; Bain, Stephen; Rossing, Peter; Sco 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 194 KB

Pioglitazone does not affect the risk of

Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes

✍ Tseng, Chin-Hsiao 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 237 KB

1969 DIABETES MELLITUS DOES NOT AFFECT T

1969 DIABETES MELLITUS DOES NOT AFFECT THE EFFICACY AND SAFETY OF INTRAVESICAL BOTUNILUM TOXIN TYPE A INJECTION ON PATIENTS WITH OAVERACTIVE BLADDER

✍ Wang, Chung-Cheng; Kuo, Hann-Chorng 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

Efficacy and Safety of the Dietary Suppl

Efficacy and Safety of the Dietary Supplement DBCare® in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control

✍ Rotman-Pikielny, Pnina; Ness-Abramof, Rosane; Charach, Gideon; Roitman, Alexande 📂 Article 📅 2014 🏛 Informa UK (Taylor & Francis) 🌐 English ⚖ 142 KB

Safety and efficacy of liraglutide in pa

Safety and efficacy of liraglutide in patients with type 2 diabetes with elevated liver enzymes: individual patient data meta-analysis of the LEAD programme

✍ Armstrong, MJ; Houlihan, DD; Rowe, IA; Clausen, WHO; Elbrønd, B; Gough, SCL; Tom 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 48 KB